The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth ...

Walgreens Boots Alliance entered into a $10 billion definitive agreement with private equity firm Sycamore Partners to take ...

Walgreens tapped health-care industry veteran Tim Wentworth as its new CEO in late 2023 to help regain its footing. The company has reportedly been seen as a potential private equity target in the ...

Walgreens Boots Alliance Inc. shares ended ... resulted in continued negative free cash flow," Chief Executive Tim Wentworth said in a statement. The company, he added, is still in the early ...

Walgreens CEO Tim Wentworth confirmed in January that a sale process for the business was underway. Including debt, the value of the deal is just under $24 billion, the company said. Walgreens said ...

Walgreens CEO Tim Wentworth said in a statement that fiscal 2025, which began last month, will be an important "rebasing year" for the drugstore chain. "This turnaround will take time, but we are ...

Walgreens (NASDAQ:WBA ... GuruFocus has detected 3 Warning Signs with WBA. CEO Tim Wentworth isn't sugarcoating it. He called this a turnaroundone that's going to take time, but one the company ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Reports Q2 revenue $38.59B, consensus $37.9B. CEO Tim Wentworth said: “Second quarter results reflect disciplined cost management and ...

improving cash flow and continuing to address reimbursement models to support dispensing margins and preserve patient access for the future,” Tim Wentworth, Walgreens Boots Alliance CEO said in ...

Walgreens is closing nine locations in Massachusetts, including one in Dorchester, as it aims to implement cost-cutting measures.